Osiris Therapeutics (OSIR)

18.99 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- M&A (6/30/19 *Est)

Latest Headlines

Form 25-NSE OSIRIS THERAPEUTICS, Filed by: The Nasdaq Stock Market LLC April 17, 2019 9:48 AM - SEC Filing Form 4 OSIRIS THERAPEUTICS, For: Apr 17 Filed by: FRIEDLI PETER April 17, 2019 9:37 AM - SEC Filing Form 4 OSIRIS THERAPEUTICS, For: Apr 17 Filed by: Keefer Jason April 17, 2019 9:37 AM - SEC Filing Form 4 OSIRIS THERAPEUTICS, For: Apr 17 Filed by: Danilkovitch Alla April 17, 2019 9:36 AM - SEC Filing Form S-8 POS OSIRIS THERAPEUTICS, April 17, 2019 9:19 AM - SEC Filing Form S-8 POS OSIRIS THERAPEUTICS, April 17, 2019 9:18 AM - SEC Filing Form S-8 POS OSIRIS THERAPEUTICS, April 17, 2019 9:18 AM - SEC Filing Form S-8 POS OSIRIS THERAPEUTICS, April 17, 2019 9:18 AM - SEC Filing Form S-8 POS OSIRIS THERAPEUTICS, April 17, 2019 9:18 AM - SEC Filing Form 8-K OSIRIS THERAPEUTICS, For: Apr 17 April 17, 2019 9:15 AM - SEC Filing Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plc April 17, 2019 9:05 AM - Globe NewsWire Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plc April 17, 2019 9:05 AM - StreetInsider Form SC 14D9/A OSIRIS THERAPEUTICS, Filed by: OSIRIS THERAPEUTICS, INC. April 17, 2019 6:08 AM - SEC Filing Form SC TO-T/A OSIRIS THERAPEUTICS, Filed by: SMITH & NEPHEW PLC April 17, 2019 6:08 AM - SEC Filing Form SC 14D9/A OSIRIS THERAPEUTICS, Filed by: OSIRIS THERAPEUTICS, INC. April 16, 2019 9:03 AM - SEC Filing Form SC TO-T/A OSIRIS THERAPEUTICS, Filed by: SMITH & NEPHEW PLC April 12, 2019 8:57 AM - SEC Filing Form SC 14D9/A OSIRIS THERAPEUTICS, Filed by: OSIRIS THERAPEUTICS, INC. April 10, 2019 9:34 AM - SEC Filing Form SC TO-T/A OSIRIS THERAPEUTICS, Filed by: SMITH & NEPHEW PLC April 10, 2019 9:30 AM - SEC Filing Form SC TO-T/A OSIRIS THERAPEUTICS, Filed by: SMITH & NEPHEW PLC March 27, 2019 5:19 PM - SEC Filing Form SC 14D9/A OSIRIS THERAPEUTICS, Filed by: OSIRIS THERAPEUTICS, INC. March 27, 2019 5:13 PM - SEC Filing Form SC 14D9 OSIRIS THERAPEUTICS, Filed by: OSIRIS THERAPEUTICS, INC. March 20, 2019 7:43 AM - SEC Filing Form SC TO-T OSIRIS THERAPEUTICS, Filed by: SMITH & NEPHEW PLC March 20, 2019 7:32 AM - SEC Filing Form 10-K OSIRIS THERAPEUTICS, For: Dec 31 March 15, 2019 9:03 AM - SEC Filing Form SC14D9C OSIRIS THERAPEUTICS, Filed by: OSIRIS THERAPEUTICS, INC. March 12, 2019 5:10 PM - SEC Filing Form 8-K OSIRIS THERAPEUTICS, For: Mar 12 March 12, 2019 5:06 PM - SEC Filing Form SC TO-C OSIRIS THERAPEUTICS, Filed by: SMITH & NEPHEW PLC March 12, 2019 5:03 PM - SEC Filing Smith & Nephew expands in high growth regenerative medicine market through acquisition of Osiris Therapeutics, Inc. March 12, 2019 9:33 AM - PR NewsWire Form SC14D9C OSIRIS THERAPEUTICS, Filed by: OSIRIS THERAPEUTICS, INC. March 12, 2019 9:22 AM - SEC Filing Form 8-K OSIRIS THERAPEUTICS, For: Mar 12 March 12, 2019 9:17 AM - SEC Filing UPDATE: NuVasive (NUVA) Declines on Osiris Therapeutics (OSIR)/Smith & Nephew (SNN) Deal March 12, 2019 9:05 AM - StreetInsider Osiris Therapeutics, Inc. Enters Agreement to be Acquired by Smith & Nephew plc March 12, 2019 9:02 AM - Globe NewsWire Osiris Therapeutics (OSIR) to be Acquired by Smith & Nephew (SNN) for $19/Share March 12, 2019 9:02 AM - StreetInsider Osiris Therapeutics, Inc. Enters Agreement to be Acquired by Smith & Nephew plc March 12, 2019 9:01 AM - StreetInsider Osiris Therapeutics (OSIR) Halted, News Pending March 12, 2019 8:55 AM - StreetInsider Predictive Technology Group Names Jay M. Moyes to Its Board of Directors February 28, 2019 9:02 AM - Globe NewsWire Predictive Technology Group Names Jay M. Moyes to Its Board of Directors February 28, 2019 9:00 AM - StreetInsider Full Article List